Holen Sie sich die Stockscreener-App
18.73
1.41%
0.26
Handel nachbörslich:
18.73
Schlusskurs vom Vortag:
$18.47
Offen:
$18.64
24-Stunden-Volumen:
245.47K
Relative Volume:
0.77
Marktkapitalisierung:
$759.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-136.98M
KGV:
-4.6592
EPS:
-4.02
Netto-Cashflow:
$-126.63M
1W Leistung:
+0.70%
1M Leistung:
+1.52%
6M Leistung:
-11.90%
1J Leistung:
-36.16%
1-Tages-Spanne:
$18.00
$18.98
1-Wochen-Bereich:
$18.00
$20.04
52-Wochen-Spanne:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Firmenname
Arrivent Biopharma Inc
Sektor
Branche
Telefon
240-780-6356
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Vergleichen Sie AVBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
18.73 | 749.31M | 0 | -136.98M | -126.63M | -4.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-03-20 | Eingeleitet | B. Riley Securities | Buy |
| 2025-03-10 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-02-20 | Eingeleitet | Citigroup | Buy |
| 2024-02-20 | Eingeleitet | Goldman | Buy |
| 2024-02-20 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten
Evaluating ArriVent BioPharma Inc. with trendline analysisJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Published on: 2025-11-02 12:15:30 - newser.com
Is ArriVent BioPharma Inc. stock a defensive play in 2025Portfolio Risk Summary & Pattern Based Trade Signal System - newser.com
Why ArriVent BioPharma Inc. stock could benefit from AI revolutionShare Buyback & High Accuracy Trade Alerts - newser.com
Multi asset correlation models including ArriVent BioPharma Inc.2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Real time pattern detection on ArriVent BioPharma Inc. stockMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Best data tools to analyze ArriVent BioPharma Inc. stock2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Moody Aldrich Partners LLC Takes $1.56 Million Position in ArriVent BioPharma, Inc. $AVBP - MarketBeat
Why retail investors pile into ArriVent BioPharma Inc. stockJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - newser.com
Is ArriVent BioPharma Inc a good long term investmentEarnings Surprise Analysis & High Profit Trading Alerts - earlytimes.in
ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment - TipRanks
How ArriVent BioPharma Inc. stock reacts to Fed rate cutsJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
Momentum divergence signals in ArriVent BioPharma Inc. chartBull Run & Daily Risk Controlled Trade Plans - newser.com
What is the fair value of ArriVent BioPharma Inc. stock nowPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Is ArriVent BioPharma Inc. meeting your algorithmic filter criteriaPortfolio Performance Report & Real-Time Stock Movement Alerts - newser.com
Why ArriVent BioPharma Inc. stock is favored by pension funds2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Is ArriVent BioPharma Inc. stock in correction or buying zoneQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
Will ArriVent BioPharma Inc. stock gain from lower inflation2025 Earnings Surprises & Verified Technical Trade Signals - newser.com
Analyzing ArriVent BioPharma Inc. with risk reward ratio chartsTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-10-28 03:24:22 - newser.com
Why ArriVent BioPharma Inc. stock remains a top recommendationJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - fcp.pa.gov.br
Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):